Michael Atieh
Fortune : 12 M $ au 31/05/2026
Fortune : 12 M $ au 31/05/2026
Michael G.
Atieh is currently an Independent Director at Chubb Ltd. since 1990 and an Independent Non-Executive Director at Immatics NV since 2021.
Former positions include Executive Chairman at Eyetech, Inc. from 2009 to 2012; Independent Director at ACE Ltd. from 2012 to 2016; CFO, Treasurer, Director & Executive VP at OSI Pharmaceuticals, Inc. from 2005 to 2008; Director at Clintrak Clinical Labeling Services LLC from 2004 to 2006; Independent Director at electroCore, Inc. from 2021 to 2022; Independent Director at Theravance Biopharma, Inc. from 2014 to 2015; Independent Director at Oyster Point Pharma, Inc. from 2020 to 2023; Treasurer & Vice President-US Human Health at Merck & Co., Inc. from 1999 to 2000; Group President at Dendrite International, Inc. from 2002 to 2004; Senior Vice President at Merck-Medco Managed Care LLC from 1994 to 1998; Chief Financial & Business Officer, Treasurer, EVP at IVERIC bio, Inc. from 2014 to 2016; Audit Manager at Ernst & Young SA from 1975 to 1981; and CFO, Group President-Global Business Unit & SVP at Cegedim, Inc. Education includes an undergraduate degree from Upsala College conferred in 1975.
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
CHUBB LIMITED 0,01 % | 21/05/2026 | 40 014 ( 0,01 % ) | 12 M $ | 31/05/2026 |
IMMATICS N.V. -.--% | 16/06/2026 | 0 ( -.--% ) | - $ | 31/05/2026 |
| Sociétés | Poste | Début |
|---|---|---|
| CHUBB LIMITED | Directeur/Membre du Conseil | 01/01/1990 |
| IMMATICS N.V. | Directeur/Membre du Conseil | 01/07/2020 |
| Sociétés | Poste | Fin |
|---|---|---|
| OYSR POIN | Directeur/Membre du Conseil | 03/01/2023 |
| ELECTROCORE, INC. | Président | 01/10/2021 |
| IVERIC BIO, INC. | Directeur Financier/CFO | 31/03/2016 |
ACE Ltd.
ACE Ltd. Multi-Line InsuranceFinance Operates as a holding company which provides commercial property & casualty insurance, and reinsurance products and services | Directeur/Membre du Conseil | 14/01/2016 |
| THERAVANCE BIOPHARMA, INC. | Directeur/Membre du Conseil | 22/04/2015 |
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
| Entreprise privées | 16 |
|---|---|
ACE Ltd.
ACE Ltd. Multi-Line InsuranceFinance Operates as a holding company which provides commercial property & casualty insurance, and reinsurance products and services | Finance |
OSI Pharmaceuticals, Inc.
OSI Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and develops pharmaceutical drugs | Health Technology |
Merck & Co., Inc.
Merck & Co., Inc. Pharmaceuticals: MajorHealth Technology Manufactures human and animal health pharmaceutical products & vaccines | Health Technology |
Dendrite International, Inc.
Dendrite International, Inc. Packaged SoftwareTechnology Services Provides sales force software products and support services | Technology Services |
Eyetech, Inc.
Eyetech, Inc. Medical SpecialtiesHealth Technology Provides ophthalmic biotechnology services | Health Technology |
Merck-Medco Managed Care LLC
Merck-Medco Managed Care LLC Pharmaceuticals: MajorHealth Technology Discovers, develops, and markets a broad range of human and animal health products | Health Technology |
Clintrak Clinical Labeling Services LLC
Clintrak Clinical Labeling Services LLC Miscellaneous Commercial ServicesCommercial Services Provides healthcare integration services company that unites health plans and clinical laboratories | Commercial Services |
IVERIC bio, Inc.
IVERIC bio, Inc. BiotechnologyHealth Technology Operates as a science-driven biopharmaceutical company that develops novel treatments for retinal diseases | Health Technology |
Upsala College
Upsala College Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Ernst & Young SA
Ernst & Young SA Investment ManagersFinance Provides investment advisory services | Finance |
electroCore, Inc.
electroCore, Inc. Medical SpecialtiesHealth Technology Develops non-invasive neuromodulation therapies | Health Technology |
Theravance Biopharma, Inc.
Theravance Biopharma, Inc. Pharmaceuticals: MajorHealth Technology Engages in the discovery, development and commercialization of human therapeutics products for respiratory diseases | Health Technology |
Cegedim, Inc.
Cegedim, Inc. Packaged SoftwareTechnology Services Cegedim, Inc. specializes in integrated, modular digital solutions that optimize payroll, human resources, billing, purchasing, and supply chain processes across sectors such as healthcare, pharmaceuticals, automotive, telecom, media, industry, commerce, tourism, banking, and transport. The company is based in Bedminster, NJ. The company supports businesses, healthcare establishments, and suppliers by enabling digital transformation focused on regulatory compliance, operational efficiency, and data security. Its HR management system automates payroll cycles, time management, talent development, and social reporting, with real-time integration and compliance with collective agreements. Additional products streamline temporary staffing management, enhance workforce and resource planning, and automate complex billing and purchasing workflows. In healthcare, solutions digitalize commercial and logistical operations, ensuring traceability, supply chain security, and regulatory adherence. Cegedim emphasizes data protection, hosting data securely with certifications and compliance with GDPR and French data protection laws, and integrates artificial intelligence to enhance operational advice, automate invoice processing, and optimize resource planning. | Technology Services |
Chubb Ltd.
Chubb Ltd. Property/Casualty InsuranceFinance Operates as a holding company for a family of property and casualty insurance companies | Finance |
Oyster Point Pharma, Inc.
Oyster Point Pharma, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a clinical stage biopharmaceutical company that develops and commercializes pharmaceutical therapies to treat ocular surface diseases | Commercial Services |
Immatics NV
Immatics NV Pharmaceuticals: MajorHealth Technology Engages in developing immunotherapies for cancer treatments | Health Technology |
Sélectionnez votre édition
Toutes les informations financières adaptées au niveau national